Krystal Biotech, Inc. KRYS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s total assets?
- Krystal Biotech, Inc. (KRYS) reported total assets of $1.4B in Q1 2026.
- How has Krystal Biotech, Inc.'s total assets changed year-over-year?
- Krystal Biotech, Inc.'s total assets increased by 30.0% year-over-year, from $1.07B to $1.4B.
- What is the long-term trend for Krystal Biotech, Inc.'s total assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s total assets has grown at a 33.8% compound annual growth rate (CAGR), from $310.84M to $1.33B.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- An increase generally reflects growth in the company's operational capacity or cash position, while a decrease may signal asset liquidation or impairment.
- How does total assets compare across companies?
- Standard metric across all industries; scale is highly dependent on the company's business model and capital intensity.